Adjuvant Therapy for Cutaneous Melanoma

Darryl Schuitevoerder, Charles C. Vining, Jennifer Tseng

Research output: Contribution to journalReview articlepeer-review

2 Scopus citations


This article presents the current data supporting adjuvant therapy for patients with cutaneous melanoma. With the recent development of novel immunotherapy agents as well as targeted therapy, there are strong data to support the use of these therapies in patients at high risk of developing recurrent or metastatic disease.

Original languageEnglish (US)
Pages (from-to)455-465
Number of pages11
JournalSurgical Oncology Clinics of North America
Issue number3
StatePublished - Jul 2020

All Science Journal Classification (ASJC) codes

  • Surgery
  • Oncology


Dive into the research topics of 'Adjuvant Therapy for Cutaneous Melanoma'. Together they form a unique fingerprint.

Cite this